Assembly Biosciences
Founded in 2005, Assembly Biosciences is a clinical stage biopharmaceutical company that creates solutions to infectious diseases that is headquartered in New York. They are focused on new treatments for hepatitis B virus (HBV) and C. difficile-associated diarrhea (CDAD). They have development facilities in San Francisco, CA and New York, NY.
Last updated on
About Assembly Biosciences
Founded
2014Estimated Revenue
$1M-$10MEmployees
51-250Funding / Mkt. Cap
$21MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
2834NAICs Code
541Location
City
South San FranciscoState
CaliforniaCountry
United StatesAssembly Biosciences
Find your buyer within Assembly Biosciences
Tech Stack (68)
